Martin J. Madden, Director at NovoCure Ltd (NVCR), sold 34 shares at $153.13 ($5K) on 2021-08-05, disclosed to the SEC on 2021-08-06.
Open-market sale of $5k NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.